Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Kimura T, McKolanis JR, Dzubinski LA, Islam K, Potter DM, Salazar AM, Schoen RE, Finn OJ.

Cancer Prev Res (Phila). 2013 Jan;6(1):18-26. doi: 10.1158/1940-6207.CAPR-12-0275. Epub 2012 Dec 17.

2.

Mumps and ovarian cancer: modern interpretation of an historic association.

Cramer DW, Vitonis AF, Pinheiro SP, McKolanis JR, Fichorova RN, Brown KE, Hatchette TF, Finn OJ.

Cancer Causes Control. 2010 Aug;21(8):1193-201. doi: 10.1007/s10552-010-9546-1. Epub 2010 Jun 18.

3.

Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.

Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ, Cramer DW.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1595-601. doi: 10.1158/1055-9965.EPI-10-0068. Epub 2010 May 25.

4.

A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.

Lepisto AJ, Moser AJ, Zeh H, Lee K, Bartlett D, McKolanis JR, Geller BA, Schmotzer A, Potter DP, Whiteside T, Finn OJ, Ramanathan RK.

Cancer Ther. 2008;6(B):955-964.

5.

Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.

Terry KL, Titus-Ernstoff L, McKolanis JR, Welch WR, Finn OJ, Cramer DW.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):30-5.

6.

Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer.

Cramer DW, Titus-Ernstoff L, McKolanis JR, Welch WR, Vitonis AF, Berkowitz RS, Finn OJ.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1125-31.

7.

Mucins in gastrointestinal cancers.

Turner MS, McKolanis JR, Ramanathan RK, Whitcomb DC, Finn OJ.

Cancer Chemother Biol Response Modif. 2003;21:259-74. Review.

PMID:
15338749
8.

Analysis of the frequency of MHC-unrestricted MUC1-specific cytotoxic T-cells in peripheral blood by limiting dilution assay.

McKolanis JR, Finn OJ.

Methods Mol Biol. 2000;125:463-70. Review. No abstract available.

PMID:
10820782
9.
10.
11.

Characterization of human myelomonocytic antigens using monoclonal antibodies.

McKolanis JR, Finn OJ, Metzgar RS.

Prog Clin Biol Res. 1983;133:145-56. No abstract available.

PMID:
6622491
12.
13.

Protein-A antibody-binding TPAAB) technique for detection of tumor-associated membrane antigen (TAMA) of Lewis lung carcinoma.

Veltri RW, McKolanis JR, Rockoff SD, McIntire KR.

Int J Cancer. 1980 Jan 15;25(1):141-5.

PMID:
7399741

Supplemental Content

Loading ...
Support Center